Cargando…

Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies

Cytokine-induced Killer (CIK) cells are a heterogeneous population of ex vivo expanded T lymphocytes capable of MHC-unrestricted antitumor activity, which share phenotypic and functional features with both NK and T cells. Preclinical data and initial clinical studies demonstrated their high tolerabi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cappuzzello, Elisa, Tosi, Anna, Zanovello, Paola, Sommaggio, Roberta, Rosato, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007963/ https://www.ncbi.nlm.nih.gov/pubmed/27622068 http://dx.doi.org/10.1080/2162402X.2016.1199311

Ejemplares similares

How can Cytokine-induced killer cells overcome CAR-T cell limits
por: Cappuzzello, Elisa, et al.
Publicado: (2023)

Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells
por: Sommaggio, Roberta, et al.
Publicado: (2020)

Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1
por: Tosi, Anna, et al.
Publicado: (2017)

Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells
por: Pietà, Anna Dalla, et al.
Publicado: (2021)

Impact of γ-chain cytokines on EBV-specific T cell cultures
por: Merlo, Anna, et al.
Publicado: (2010)

Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development
por: Abozeid, Mohamed, et al.
Publicado: (2017)

A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors
por: Turrini, Riccardo, et al.
Publicado: (2017)

Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016)

Retargeting of Viruses to Generate Oncolytic Agents
por: Verheije, M. H., et al.
Publicado: (2012)

Retargeting the management of hypercholesterolemia – focus on evolocumab
por: Colletti, Alessandro, et al.
Publicado: (2016)

Endothelial Retargeting of AAV9 In Vivo
por: Bozoglu, Tarik, et al.
Publicado: (2022)

Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment
por: De Lucia, Maria, et al.
Publicado: (2020)

Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity
por: Boissel, Laurent, et al.
Publicado: (2013)

Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
por: Niemann, Julia, et al.
Publicado: (2019)

Development of a Bispecific Antibody-Based Platform for Retargeting of Capsid Modified AAV Vectors
por: Kuklik, Juliane, et al.
Publicado: (2021)

Retargeted adenoviruses for radiation-guided gene delivery
por: Kaliberov, S A, et al.
Publicado: (2016)

Tools for retargeting proteins within Aspergillus nidulans
por: Suresh, Subbulakshmi, et al.
Publicado: (2017)

Characterization of BIS20x3, a bi-specific antibody activating and retargeting T-cells to CD20-positive B-cells
por: Withoff, S, et al.
Publicado: (2001)

Characterization of a Novel Single-Chain Bispecific Antibody for Retargeting of T Cells to Tumor Cells via the TCR Co-Receptor CD8
por: Michalk, Irene, et al.
Publicado: (2014)

Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
por: Whalen, Kerry A., et al.
Publicado: (2023)

Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy
por: Nikkhoi, Shahryar Khoshtinat, et al.
Publicado: (2023)

Retargeting T Cells for HER2-Positive Tumor Killing by a Bispecific Fv-Fc Antibody
por: Wang, Lei, et al.
Publicado: (2013)

CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL
por: Reusing, Sarah B., et al.
Publicado: (2021)

HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses
por: Menotti, Laura, et al.
Publicado: (2018)

Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
por: Bachmann, Dominik, et al.
Publicado: (2017)

Retargeting Adenoviral Vectors to Improve Gene Transfer into Tumors
por: Hogg, Richard T., et al.
Publicado: (2010)

Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL
por: Reusing, Sarah B., et al.
Publicado: (2021)

Site-Specific Glycation and Chemo-enzymatic Antibody Sortagging for the Retargeting of rAAV6 to Inflamed Endothelium
por: Pearce, Hannah A., et al.
Publicado: (2019)

Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer
por: Turrini, Riccardo, et al.
Publicado: (2011)

Image content retargeting: maintaining color, tone, and spatial consistency
por: Artusi, Alessandro, et al.
Publicado: (2016)

Improved content aware scene retargeting for retinitis pigmentosa patients
por: Al-Atabany, Walid I, et al.
Publicado: (2010)

Retargeted Clostridial Neurotoxins as Novel Agents for Treating Chronic Diseases
por: Yeh, Felix L., et al.
Publicado: (2011)

Retargeting transposon insertions by the adeno-associated virus Rep protein
por: Ammar, Ismahen, et al.
Publicado: (2012)

Retargeting the Clostridium botulinum C2 toxin to the neuronal cytosol
por: Pavlik, Benjamin J., et al.
Publicado: (2016)

An image retrieval framework for real-time endoscopic image retargeting
por: Ye, Menglong, et al.
Publicado: (2017)

Retargeting azithromycin analogues to have dual-modality antimalarial activity
por: Burns, Amy L., et al.
Publicado: (2020)

RNA-guided retargeting of Sleeping Beauty transposition in human cells
por: Kovač, Adrian, et al.
Publicado: (2020)

MicroRNA profiling of CD3(+)CD56(+) cytokine-induced killer cells
por: Wang, Wenju, et al.
Publicado: (2015)

Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
por: Appolloni, Irene, et al.
Publicado: (2021)

Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts
por: Aliperta, R, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1jsvlrekksloccak65ochgd4dr